First, the majority of NKT cells express an invariant (i) TCRα

chain, which is encoded by a Vα14-Jα18 rearrangement in mice and a Vα24-Jα18 rearrangement in humans (1–4). These cells are referred to as Vα14iNKT cells and Vα24iNKT cells, respectively; Everolimus cost collectively they are referred to as iNKT cells (4). Second, in contrast to conventional T cells, which recognize peptide antigens presented by MHC class I or class II, iNKT cells recognize glycolipids presented by the CD1d molecule. Third, iNKT cells rapidly (within 1–2 hr) produce large quantities of cytokines (including IFNγ and IL-4) following glycolipid antigen recognition by their invariant TCRs. Consequently, iNKT cells stimulate many types of cells including APCs, NK cells, conventional T cells and B cells. Because of these unique features, iNKT cells are able to participate in various immune responses including tumor immunity,

microbial immunity, and initiation and/or regulation of autoimmune diseases and asthma. CD1 is an MHC class I-like antigen presenting Wnt drug molecule (5–8). Humans express five CD1 proteins (CD1a-e), but mice and rats have CD1d only (6–8). Similar to MHC class I, CD1 molecules have three extracellular domains (α1, α2 and α3), which bind to β2 microglobulin. CD1 molecules have deep, narrow and hydrophobic antigen-binding grooves that are suitable for lipid antigen presentation (5–8). CD1a, CD1b and CD1c proteins present lipid antigens from mycobacteria or endogenous lipids to CD1 restricted T cells, and CD1e functions in antigen processing (6–8). The

CD1d protein is necessary for thymic development of iNKT cells and glycolipid antigen presentation to these cells (1–4). Many studies have shown that iNKT cells participate in the response to various microbial pathogens (2, 4, 9, 10). iNKT cell deficient mice are susceptible selleck compound to certain microbial pathogens including bacteria, fungi, parasites and viruses (2, 4, 9, 10). However, in some cases, iNKT cells do not play a role in the clearance of microbes, and they may have a detrimental impact on the host (2, 4, 9, 10). In this article, we review recent findings on the role of iNKT cells in the response to microbial pathogens and the mechanisms by which iNKT cells contribute to antimicrobial responses. We also describe how iNKT cell TCR contributes to the response to certain microbial pathogens by recognizing microbial glycolipid antigens. Furthermore, we summarize data indicating that iNKT cell glycolipid antigens may be useful as stimulatory agents that augment immune responses to certain microbial pathogens. Natural killer T cells expressing an invariant T cell antigen receptor are considered innate type lymphocytes because of their rapid cytokine production and NK receptor expression. iNKT cells participate in the response to certain microbial pathogens in the early phase of infection. For example, a role for NKT cells was shown in mice infected with S.